SCHEMBL10132047

SCHEMBL10132047

O=C(Oc1ccccc1C(=O)Nc1ncc(S)s1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
NPC1 O15118 5/20 0.51
ALDH1A1 P00352 5/20 0.51
MAPT P10636 4/20 0.51
RAB9A P51151 4/20 0.51
LMNA P02545 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
SLC6A3 Q01959 2/20 0.51
TSHR P16473 2/20 0.51
PKM P14618 2/20 0.51
STAT3 P40763 2/20 0.51
MEN1 O00255 1/20 0.51
MLNR O43193 1/20 0.51
NR1I2 O75469 1/20 0.51
ABCB11 O95342 1/20 0.51
TP53 P04637 1/20 0.51
ADRB2 P07550 1/20 0.51
CHRM2 P08172 1/20 0.51
ADRB1 P08588 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23510811 0.85 NPC1 (0.50) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL12994092 0.83 KMT2A (0.65) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL16687816 0.83 KMT2A (0.62) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL4938035 0.83 ALDH1A1 (0.48) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL10169728 0.83 RAB9A (0.61) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL10131745 0.82 NPC1 (0.53) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL16687501 0.82 NPC1 (0.77) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL4757584 0.82 KMT2A (0.50) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL10131508 0.81 ALDH1A1 (0.51) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL4939291 0.79 ALDH1A1 (0.47) KMT2ANPC1ALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC KMT2A 2303/4885NPC1 585/4885ALDH1A1 1605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.